Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Béatrice Guardiola

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal De La Societe De Biologie|September 1, 2007
[Melatoninergic receptor agonists and antagonists: therapeutic perspectives]Béatrice Guardiola-Lemaitre
Lancet (London, England)|June 14, 2011
Mediator: who's to blame?Lucy Vincent, Béatrice Guardiola, Yannis Tsouderos, et al.
Psychoneuroendocrinology|August 30, 2008
Short day-length increases sucrose consumption and adiposity in rats fed a high-fat dietNatalia Sinitskaya, Carole Schuster-Klein, Béatrice Guardiola-Lemaitre, et al.
Clinical Science (London, England : 1979)|July 5, 2007
Increasing the fat-to-carbohydrate ratio in a high-fat diet prevents the development of obesity but not a prediabetic state in ratsNatalia Sinitskaya, Sylviane Gourmelen, Carole Schuster-Klein, et al.
Nature Reviews. Drug Discovery|June 26, 2010
Agomelatine, the first melatonergic antidepressant: discovery, characterization and developmentChristian de Bodinat, Béatrice Guardiola-Lemaitre, Elisabeth Mocaër, et al.
Journal of Pineal Research|July 9, 2010
In vitro and in vivo antitumor activity of melatonin receptor agonistsLulu Mao, Qi Cheng, Béatrice Guardiola-Lemaître, et al.
Neuropharmacology|April 28, 2004
Melatonin MT(1/2) receptor stimulation reduces cortical overflow of cholecystokinin-like material in a model of anticipation of social defeat in the ratChrystel Becker, Judith Andre, Brigitte Zeau, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal De La Societe De Biologie|September 1, 2007
[Melatoninergic receptor agonists and antagonists: therapeutic perspectives]Béatrice Guardiola-Lemaitre
Lancet (London, England)|June 14, 2011
Mediator: who's to blame?Lucy Vincent, Béatrice Guardiola, Yannis Tsouderos, et al.
Psychoneuroendocrinology|August 30, 2008
Short day-length increases sucrose consumption and adiposity in rats fed a high-fat dietNatalia Sinitskaya, Carole Schuster-Klein, Béatrice Guardiola-Lemaitre, et al.
Clinical Science (London, England : 1979)|July 5, 2007
Increasing the fat-to-carbohydrate ratio in a high-fat diet prevents the development of obesity but not a prediabetic state in ratsNatalia Sinitskaya, Sylviane Gourmelen, Carole Schuster-Klein, et al.
Nature Reviews. Drug Discovery|June 26, 2010
Agomelatine, the first melatonergic antidepressant: discovery, characterization and developmentChristian de Bodinat, Béatrice Guardiola-Lemaitre, Elisabeth Mocaër, et al.
Journal of Pineal Research|July 9, 2010
In vitro and in vivo antitumor activity of melatonin receptor agonistsLulu Mao, Qi Cheng, Béatrice Guardiola-Lemaître, et al.
Neuropharmacology|April 28, 2004
Melatonin MT(1/2) receptor stimulation reduces cortical overflow of cholecystokinin-like material in a model of anticipation of social defeat in the ratChrystel Becker, Judith Andre, Brigitte Zeau, et al.
Pageof 1